NEW YORK (GenomeWeb) – MDxHealth today reported that its third quarter revenues increased 17 percent year over year, driven by sales of its ConfirmMDx for Prostate Cancer test.

The Belgian molecular diagnostics firm reported total revenues of $4.1 million for the three months ended Sept. 30, up from $3.5 million in the third quarter of 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.